# Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Clinical trial · Hoffmann-La Roche

- Archive id: nct:NCT07177352
- Published: 2025-09-17
- Venue: ClinicalTrials.gov
- ClinicalTrials.gov: https://clinicaltrials.gov/study/NCT07177352
- Source URL: https://clinicaltrials.gov/study/NCT07177352
- Provenance: clinicaltrials

## Abstract

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

_Abstract reproduced under ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters._

## Trial details

- acronym: TRAVELLER
- status: RECRUITING
- phase: PHASE3
- study type: INTERVENTIONAL
- enrollment: 80000
- sponsor: Hoffmann-La Roche
- conditions: Alzheimers Disease
- interventions: OTHER: No Intervention
- start date: 2025-07-02
- start date type: ACTUAL
- primary completion date: 2035-07-31
- has results: false
- data source: ClinicalTrials.gov
- data processed: 2026-10-29T09:00:05
- modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.